SMS Lifesciences India informs about receipt of EIR

16 Jul 2025 Evaluate

In continuation to its earlier communication dated May 9, 2025 regarding the USFDA inspection, SMS Lifesciences India has informed that the Company has received Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. Food and Drug Administration for its API manufacturing facility (Unit 1) located at Kazipally, Telangana, on July 15, 2025 at 09.37 pm. The receipt of EIR reaffirms the Company’s commitment to maintaining global quality standards and enables access to the regulated US market and other highly regulated global markets.

The above information is a part of company’s filings submitted to BSE.

Haleos Labs Share Price

1224.15 -61.65 (-4.79%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×